All In Biotech

Drug Trial Radar · NCT02314676

Phase IV Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children

Last checked: Nov 19, 2026Latest source record: Dec 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

900

Planned (sponsor's estimate)

Start

Nov 2014

Primary completion

Jul 2017

Sponsor

Sponsor type
Industry
First posted
Dec 11, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 3 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the safety and efficiency of Pegylated Somatropin (PEG Somatropin) Injection in the treatment of endogenous growth hormone deficiency (GHD) in the broad population of children. Half of participants will receive the high dose, while the other half will receive the low dose.

Conditions

  • Dwarfism, Pituitary

Interventions

  • PEG-somatropinBiological

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Actual height of the patient after treatment compared with the mean height of the population and the standard deviation (SD) of the height of the population for that chronological ageTime frame: 26 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • First People's Hospital of Wuhu

    Wuhu, Anhui, China · Recruiting

  • Children's Hospital Affiliated to Zhejiang University

    Hangzhou, Zhejiang, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.